133 related articles for article (PubMed ID: 12969739)
1. Prognostic value of VEGF levels for ovarian hyperstimulation.
Bussen S; Dietl J
Fertil Steril; 2003 Sep; 80(3):681-2; author reply 682. PubMed ID: 12969739
[No Abstract] [Full Text] [Related]
2. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
Mathur R; Hayman G; Bansal A; Jenkins J
Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
[TBL] [Abstract][Full Text] [Related]
3. Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others?
McElhinney B; Ardill J; Caldwell C; Lloyd F; McClure N
Hum Reprod; 2002 Jun; 17(6):1548-53. PubMed ID: 12042276
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of VEGF do not correlate with the severity of multiple myeloma.
Jakob C; Zavrski I; Heider U; Langelotz C; Eucker J; Possinger K; Sezer O
Br J Haematol; 2002 Oct; 119(1):276; author reply 276-7. PubMed ID: 12358939
[No Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor--mediator of OHSS?
McDonough PG
Fertil Steril; 2003 Jun; 79(6):1466-7. PubMed ID: 12798907
[No Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor-mediator of PHSS?
Kol S
Fertil Steril; 2003 Jun; 79(6):1466; author reply 1466. PubMed ID: 12798905
[No Abstract] [Full Text] [Related]
7. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration.
Ludwig M; Jelkmann W; Bauer O; Diedrich K
Hum Reprod; 1999 Oct; 14(10):2437-41. PubMed ID: 10527964
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
9. The importance of the VEGF-load in platelets in cancer patients.
Salgado R; Benoy I; van Marck E; Vermeulen P; Dirix L
Ann Oncol; 2002 Oct; 13(10):1689-90. PubMed ID: 12377663
[No Abstract] [Full Text] [Related]
10. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications.
Cacciola RR; Di Francesco E; Giustolisi R; Cacciola E
Haematologica; 2002 Jul; 87(7):774-5. PubMed ID: 12091131
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia.
Kähler CM; Wechselberger J; Molnar C; Prior C
Am J Respir Crit Care Med; 2003 Jan; 167(1):92-3; author reply 93. PubMed ID: 12502484
[No Abstract] [Full Text] [Related]
12. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
[TBL] [Abstract][Full Text] [Related]
13. In vivo platelet activation is associated with increased plasma levels of vascular endothelial growth factor.
Martini F; Riondino S; Basili S; Bertazzoni G; Ferroni P
J Thromb Haemost; 2003 Apr; 1(4):853-4. PubMed ID: 12871428
[No Abstract] [Full Text] [Related]
14. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in yersiniosis. A study on 157 military recruits.
Saebo A; Lassen J
Adv Exp Med Biol; 2003; 529():455-7. PubMed ID: 12756808
[No Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome.
Meldrum DR
Fertil Steril; 2002 Dec; 78(6):1170-1. PubMed ID: 12477506
[No Abstract] [Full Text] [Related]
17. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma.
Szymik-Kantorowicz S; Partyka L; Dembinska-Kiec A; Zdzienicka A
Med Pediatr Oncol; 2003 Mar; 40(3):196-7. PubMed ID: 12518353
[No Abstract] [Full Text] [Related]
19. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis.
Karayiannakis AJ; Bolanaki H; Syrigos KN; Asimakopoulos B; Polychronidis A; Anagnostoulis S; Simopoulos C
Cancer Lett; 2003 May; 194(1):119-24. PubMed ID: 12706865
[TBL] [Abstract][Full Text] [Related]
20. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.
Artini PG; Fasciani A; Monti M; Luisi S; D'Ambrogio G; Genazzani AR
Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]